Search

Unsu Jung

Supervisory Patent Examiner (ID: 243, Phone: (571)272-8506 , Office: P/3737 )

Most Active Art Unit
1641
Art Unit(s)
3737, 1641, 3768, 3792
Total Applications
405
Issued Applications
104
Pending Applications
4
Abandoned Applications
296

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5720791 [patent_doc_number] => 20060073566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Active modified hedgehog proteins' [patent_app_type] => utility [patent_app_number] => 11/273989 [patent_app_country] => US [patent_app_date] => 2005-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7523 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073566.pdf [firstpage_image] =>[orig_patent_app_number] => 11273989 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/273989
Active modified hedgehog proteins Nov 14, 2005 Abandoned
Array ( [id] => 5913559 [patent_doc_number] => 20060128621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use' [patent_app_type] => utility [patent_app_number] => 11/273724 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4212 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128621.pdf [firstpage_image] =>[orig_patent_app_number] => 11273724 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/273724
Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use Nov 13, 2005 Abandoned
Array ( [id] => 4797182 [patent_doc_number] => 20080008768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Compositions and Methods for Inhibiting Sonic Hedgehog Activity' [patent_app_type] => utility [patent_app_number] => 11/718752 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6033 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20080008768.pdf [firstpage_image] =>[orig_patent_app_number] => 11718752 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/718752
Compositions and Methods for Inhibiting Sonic Hedgehog Activity Nov 8, 2005 Abandoned
Array ( [id] => 5637464 [patent_doc_number] => 20060068437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Meg-3 protein' [patent_app_type] => utility [patent_app_number] => 11/242604 [patent_app_country] => US [patent_app_date] => 2005-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11889 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20060068437.pdf [firstpage_image] =>[orig_patent_app_number] => 11242604 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/242604
Meg-3 protein Oct 2, 2005 Abandoned
Array ( [id] => 5272095 [patent_doc_number] => 20090075871 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2009-03-19 [patent_title] => 'Modified Thioredoxin' [patent_app_type] => utility [patent_app_number] => 10/551488 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5118 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0075/20090075871.pdf [firstpage_image] =>[orig_patent_app_number] => 10551488 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/551488
Modified Thioredoxin Sep 28, 2005 Abandoned
Array ( [id] => 5272095 [patent_doc_number] => 20090075871 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2009-03-19 [patent_title] => 'Modified Thioredoxin' [patent_app_type] => utility [patent_app_number] => 10/551488 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5118 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0075/20090075871.pdf [firstpage_image] =>[orig_patent_app_number] => 10551488 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/551488
Modified Thioredoxin Sep 28, 2005 Abandoned
Array ( [id] => 5436482 [patent_doc_number] => 20090171069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Peptides And Apl-Type Derivatives Of Hsp60 And Pharmaceutical Compositions' [patent_app_type] => utility [patent_app_number] => 11/663603 [patent_app_country] => US [patent_app_date] => 2005-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11806 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20090171069.pdf [firstpage_image] =>[orig_patent_app_number] => 11663603 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/663603
Altered peptide ligand derived from HSP60 and pharmaceutical compositions Sep 21, 2005 Issued
Array ( [id] => 5866052 [patent_doc_number] => 20060100183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Therapeutic agents targeting the NCCa-ATP channel and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/229236 [patent_app_country] => US [patent_app_date] => 2005-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 24797 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100183.pdf [firstpage_image] =>[orig_patent_app_number] => 11229236 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/229236
Methods for treating spinal cord injury with a compound that inhibits a NCCa-ATP channel Sep 15, 2005 Issued
Array ( [id] => 4618966 [patent_doc_number] => 07998682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Method for assessing atherosclerosis by measuring expression of FOS or DUSP1 in monocytes' [patent_app_type] => utility [patent_app_number] => 11/661714 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 18465 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998682.pdf [firstpage_image] =>[orig_patent_app_number] => 11661714 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/661714
Method for assessing atherosclerosis by measuring expression of FOS or DUSP1 in monocytes Sep 1, 2005 Issued
Array ( [id] => 5895396 [patent_doc_number] => 20060003935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use' [patent_app_type] => utility [patent_app_number] => 11/213024 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15025 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003935.pdf [firstpage_image] =>[orig_patent_app_number] => 11213024 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/213024
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use Aug 25, 2005 Abandoned
Array ( [id] => 4739912 [patent_doc_number] => 20080233565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'PKHDL1, a homolog of the autosomal recessive kidney disease gene' [patent_app_type] => utility [patent_app_number] => 11/202548 [patent_app_country] => US [patent_app_date] => 2005-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 22303 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233565.pdf [firstpage_image] =>[orig_patent_app_number] => 11202548 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/202548
PKHDL1, a homolog of the autosomal recessive kidney disease gene Aug 11, 2005 Abandoned
Array ( [id] => 6931196 [patent_doc_number] => 20050282231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Screening assays for hedgehog agonists and antagonists' [patent_app_type] => utility [patent_app_number] => 11/197721 [patent_app_country] => US [patent_app_date] => 2005-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 75619 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282231.pdf [firstpage_image] =>[orig_patent_app_number] => 11197721 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/197721
Hedgehog antibodies Aug 2, 2005 Issued
Array ( [id] => 5277951 [patent_doc_number] => 20090130083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Therapeutic Agents Targeting the NCCA-ATP Channel and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/574793 [patent_app_country] => US [patent_app_date] => 2005-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 39894 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130083.pdf [firstpage_image] =>[orig_patent_app_number] => 11574793 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/574793
Therapeutic methods that target the NC Jul 24, 2005 Issued
Array ( [id] => 7243509 [patent_doc_number] => 20050271656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Methods for designing specific ion channel blockers' [patent_app_type] => utility [patent_app_number] => 11/187558 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7977 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271656.pdf [firstpage_image] =>[orig_patent_app_number] => 11187558 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/187558
Methods for designing specific ion channel blockers Jul 21, 2005 Abandoned
Array ( [id] => 5539672 [patent_doc_number] => 20090221477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Linkers' [patent_app_type] => utility [patent_app_number] => 11/658526 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 9568 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221477.pdf [firstpage_image] =>[orig_patent_app_number] => 11658526 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/658526
Linkers Jul 17, 2005 Abandoned
Array ( [id] => 5373681 [patent_doc_number] => 20090311242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a)' [patent_app_type] => utility [patent_app_number] => 11/658843 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 36798 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311242.pdf [firstpage_image] =>[orig_patent_app_number] => 11658843 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/658843
Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a) Jul 17, 2005 Abandoned
Array ( [id] => 5074789 [patent_doc_number] => 20070014764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Reduction in myocardial infarction size' [patent_app_type] => utility [patent_app_number] => 11/183251 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12402 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014764.pdf [firstpage_image] =>[orig_patent_app_number] => 11183251 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/183251
Reduction in myocardial infarction size Jul 17, 2005 Abandoned
Array ( [id] => 5767797 [patent_doc_number] => 20060019346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Identification of a novel bitter taste receptor T2R76 that specifically responds to brucine and prop bitter ligands' [patent_app_type] => utility [patent_app_number] => 11/182942 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21486 [patent_no_of_claims] => 107 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019346.pdf [firstpage_image] =>[orig_patent_app_number] => 11182942 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/182942
Identification of a novel bitter taste receptor T2R76 that specifically responds to brucine and prop bitter ligands Jul 17, 2005 Abandoned
Array ( [id] => 5210424 [patent_doc_number] => 20070249008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Cardiovascular Prognostic and Diagnostic Marker' [patent_app_type] => utility [patent_app_number] => 11/631624 [patent_app_country] => US [patent_app_date] => 2005-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10916 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249008.pdf [firstpage_image] =>[orig_patent_app_number] => 11631624 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/631624
Cardiovascular Prognostic and Diagnostic Marker Jul 14, 2005 Abandoned
Array ( [id] => 800470 [patent_doc_number] => 07425614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-16 [patent_title] => 'Neuroprotective therapeutics preventing ERK/MAPK activation through the NMDA receptor' [patent_app_type] => utility [patent_app_number] => 11/181330 [patent_app_country] => US [patent_app_date] => 2005-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 15 [patent_no_of_words] => 27614 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/425/07425614.pdf [firstpage_image] =>[orig_patent_app_number] => 11181330 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/181330
Neuroprotective therapeutics preventing ERK/MAPK activation through the NMDA receptor Jul 13, 2005 Issued
Menu